Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer

Recruiting

Registered drug

Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Recruiting

Registered drug

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Baxdrostat

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

Registered drugNo placebo

Study of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Belantamab Mafodotin

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Recruiting

Registered drugNo placebo

Study of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

Investigational

A Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment

Investigational

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Hormone-refractory prostate cancer+1

Recruiting

Registered drugNo placebo

Study Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Codeine Phosphate

Contact Research Centre

Study on Golcadomide for Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Brain

Recruiting

InvestigationalNo placebo

Study on Golcadomide for Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Brain

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Golcadomide

Contact Research Centre

Rectal cancer

Recruiting

Registered drugNo placebo

Study Comparing Surgery and Chemoradiotherapy with Capecitabine for Early Rectal Cancer Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Appendicitis+4

Recruiting

Registered drugNo placebo

Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Clindamycin

Contact Research Centre

Rectal cancer

Recruiting

Registered drugNo placebo

Study on Preserving the Rectum in Early-Stage Rectal Cancer Patients Using Oxaliplatin and Capecitabine with Radiation Therapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Sepsis

Recruiting

Registered drugNo placebo

Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Amoxicillin

Contact Research Centre

Find therapies in clinical trials near you

76 trials match your criteria

Breast cancer

Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Plasma cell myeloma refractory

Study of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma

Triple negative breast cancer

Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

Hormone receptor positive HER2 negative breast cancer

Study of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk

Hormone-refractory prostate cancer

A Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment

Hormone-refractory prostate cancer+1

Study Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy

Study on Golcadomide for Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Brain

Study on Golcadomide for Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Brain

Rectal cancer

Study Comparing Surgery and Chemoradiotherapy with Capecitabine for Early Rectal Cancer Patients

Appendicitis+4

Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

Rectal cancer

Study on Preserving the Rectum in Early-Stage Rectal Cancer Patients Using Oxaliplatin and Capecitabine with Radiation Therapy

Sepsis

Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.